Deals & IPOs

Anthropic's Wall Street Debut Is the Largest IPO in History

Anthropic made the largest IPO in history at its Nasdaq debut Thursday, with CEO Dario Amodei vowing to pace AI training and deployment rather than bend to business or political pressure.

By Nathan Brooks

4 min read

At Nasdaq opening bell, Anthropic CEO recommits to pacing AI development
At Nasdaq opening bell, Anthropic CEO recommits to pacing AI developmentPIX1861 / pixabay

What's News

  • Anthropic debuted on Nasdaq Thursday in the largest IPO in history
  • CEO Dario Amodei pledged AI systems will 'remain under human control' and pledged not to bend to business or political pressure
  • His September pacing plan drew agreement from Sam Altman, Demis Hassabis, and Elon Musk, with few concrete commitments since
  • Amodei claimed AI could 'compress a century of scientific and medical progress into a decade'
  • Co-founder Daniela Amodei told CNBC the company is 'deeply committed to safety'

Anthropic rang the Nasdaq opening bell on Thursday in the largest IPO in history, and CEO Dario Amodei used the moment to promise one thing Wall Street rarely hears: the company will slow down if safety demands it.

Reading from a printout, Amodei pledged that Anthropic would not bend to business or political pressure and that its AI systems would "remain under human control." He doubled down on the pacing plan he first laid out in September, which includes coordinating safety standards with rival labs and embedding third-party evaluators to verify compliance.

That plan drew public agreement from OpenAI CEO Sam Altman, Google DeepMind chief Demis Hassabis, and xAI owner Elon Musk — though, as the record shows, few concrete commitments have followed.

Why the CEO opened with his father's story

Amodei framed Anthropic's mission through personal loss. He and his sister, co-founder Daniela Amodei, lost their father to a disease that became curable just a few years later. He started his career in biology, hoping to speed up future cures.

"Human intelligence has already made diseases like plague, smallpox, and polio history for most of the world," he said, but too many patients still wait decades between a scientific breakthrough and an approved treatment. His example: the years that separated the first discovery of a strange repeating pattern in DNA from the approval of the first CRISPR-based treatment.

His pitch to investors is that AI closes the talent gap. "Too few scientists with too little time," he said. "Now we can build that intelligence." He claimed scientists across protein folding, drug design, cancer genetics, and clinical trial administration are using Claude to do research "in a fraction of the time it would have taken just a couple of years ago."

His headline claim: sufficiently powerful AI, working with humans, "could compress a century of scientific and medical progress into a decade." He conceded these are early results — trials still take time, even if AI can substantially accelerate them.

What does this change for investors and rivals?

The tension is obvious. Public shareholders want speed; Amodei is promising restraint. His answer: capital and caution aren't in conflict, and proving it is the strategy.

"Today puts the company in a stronger financial position, and in doing so, only strengthens our resolve to do the right thing," he said. "If we can show it's possible to make the right choices on safety and still build an incredibly successful company, others in our industry will be inspired to do the same. We call this a race to the top."

That race, he argued, shouldn't be about which company has the best models. "Everyone wins because everyone is building safely." And he positioned Anthropic at the front of the pack — while insisting the goal is a better industry regardless of whether Anthropic is winning or losing at any given time.

The risks he wouldn't soft-pedal

Amodei has warned repeatedly about advancing AI too quickly, and Thursday's speech kept the warnings intact. He cited "very real risks": misuse by individuals or nation-states, "economic disruption," and "losing control of AI systems."

His framing matters for how practitioners should read it. These risks are avoidable, he argued, and avoiding them depends on the choices made by the people building AI. "There is a gigantic difference between how AI will go if we pay little attention to safety versus how it will go if we are obsessed with safety," he said.

He pointed to Anthropic's existing safeguards — protections against biological and cyber risks, alignment training and testing, and internal inspection of models "like an X-ray" — as proof the company pioneered methods for steering AI behavior.

"There is much work still to be done, and the most difficult safety work lies ahead of us," Amodei said. "The incredible talent of the company that has enabled us to build the most capable AI systems will need to be directed more so than it has already towards double and triple checking that those AI systems are safe and remain under human control."

His closing line was unambiguous: "We will pace the training and deployment of AI systems, taking as long as is necessary to have confidence that they are safe and will remain under human control."

Daniela Amodei echoed the message in a CNBC interview the same day. The risks are real, she said, but the promise of AI is "incredible." "We were really founded on this idea that it is our job to mitigate those risks, and I think we have to date done an incredible job doing that," she said. "We obviously have more work ahead of us, but we are deeply committed to safety."

The bet now on the table: the biggest IPO in history succeeds while its founder publicly promises to hit the brakes whenever safety requires it. Every earnings cycle from here tests whether the market — and Anthropic's rivals — take that seriously.

Original: cbsnews.com

Share this article:

More from Nathan Brooks

Nathan Brooks

Show full bio

News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.

2,460 articles

Related articles

« Previous article